Table 1.
Baseline characteristics of the included patients (n = 41)
| Age | 67 ± 7 | |
| Females | 9 | 22% |
| BMI (kg/m2) | 27 ± 3 | |
| Smoker | 5 | 12% |
| Previous smoker | 21 | 51% |
| Prior PCI | 17 | 41% |
| Prior CABG | 3 | 7% |
| Prior myocardial infarction | 11 | 27% |
| Diabetes | 9 | 22% |
| Hypertension | 29 | 71% |
| Hypercholesterolemia | 27 | 66% |
| Heredity for coronary artery disease | 9 | 22% |
| Betablockers | 23 | 56% |
| ACE-inhibitor/ARB | 19 | 46% |
| Statins | 36 | 88% |
| Anti-coagulants | 35 | 85% |
BMI, body mass index; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; ACE, angiotensin converting enzyme, ARB, angiotensin II receptor blockers; LGE, late gadolinium enhancement